NBY | NovaBay Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31
Revenue	14.73M	14.40M	8.42M	9.93M	6.60M	12.51M	18.23M	11.90M	4.38M	1.05M	3.48M	6.95M	11.02M	9.75M	15.68M	6.72M	5.91M	1.53M	N/A	N/A	N/A
Cost of Revenue	6.83M	6.62M	2.78M	3.97M	1.74M	1.50M	2.78M	2.46M	1.26M	486.00K	162.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	7.89M	7.78M	5.64M	5.96M	4.86M	11.01M	15.45M	9.43M	3.12M	568.00K	3.31M	N/A	11.02M	9.75M	15.68M	6.72M	N/A	1.53M	N/A	N/A	N/A
Operating Expenses	12.90M	15.46M	14.51M	12.39M	14.26M	18.88M	22.76M	20.41M	24.13M	17.45M	18.80M	15.26M	15.34M	14.27M	12.94M	15.23M	11.79M	7.06M	N/A	N/A	N/A
Selling, General & Admin	12.83M	15.29M	14.46M	12.11M	14.08M	18.62M	22.35M	19.04M	18.09M	7.93M	6.34M	5.98M	5.43M	5.65M	5.61M	5.64M	4.37M	2.97M	1.62M	N/A	N/A
Research & Development	68.00K	174.00K	44.00K	285.00K	184.00K	259.00K	410.00K	1.37M	6.04M	9.51M	12.46M	9.28M	9.91M	8.62M	7.34M	9.60M	7.42M	4.09M	1.95M	N/A	270.00K
Other Operating Expenses	-2.06M	-276.00K	-1.58M	605.00K	-1.43M	19.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-5.00M	-7.68M	-8.86M	-6.43M	-9.40M	-7.87M	-7.31M	-10.98M	-21.01M	-16.88M	-15.49M	-8.31M	-4.32M	-4.52M	2.74M	-8.51M	-5.88M	-5.53M	-3.57M	N/A	-953.00K
Other Expenses / Income	-4.64M	-2.93M	3.04M	-4.61M	-252.00K	1.33M	-89.00K	-2.17M	2.05M	1.69M	-554.00K	1.28M	-762.00K	258.00K	-36.00K	397.00K	488.00K	240.00K	106.00K	N/A	-24.00K
Before Tax Income	-9.64M	-10.61M	-5.82M	-11.03M	-9.65M	-6.54M	-7.40M	-13.15M	-18.96M	-15.19M	-16.04M	-7.03M	-5.08M	-4.26M	2.70M	-8.11M	-5.39M	-5.29M	-3.46M	N/A	-977.00K
Income Tax Expenses	35.10K	-3.81M	-4.62M	5.00K	6.00K	4.00K	3.00K	2.00K	12.00K	2.00K	2.00K	2.00K	2.00K	50.00K	7.00K	2.00K	12.00K	N/A	N/A	N/A	N/A
Net Income	-9.64M	-16.27M	-6.56M	-11.04M	-10.49M	-6.54M	-7.40M	-13.15M	-18.97M	-15.19M	-16.04M	-7.03M	-5.08M	-4.31M	2.70M	-8.11M	-5.40M	-5.29M	-3.46M	-2.80M	-977.00K
Interest Expenses	N/A	-3.81M	N/A	-129.18K	1.05M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	4.21M	1.61M	1.25M	1.00M	618.31K	483.46K	437.83K	9.41M	2.78M	1.99M	1.53M	1.18M	1.03M	933.04K	896.16K	852.48K	358.96K	228.60K	194.08K	175.12K	161.76K
Diluted Shares Outstanding	4.21M	1.61M	1.25M	1.00M	618.31K	487.37K	437.83K	9.41M	2.78M	1.99M	1.53M	1.18M	1.03M	933.04K	924.60K	852.48K	358.96K	228.60K	194.08K	175.12K	161.76K
EBITDA	-4.80M	-4.54M	-13.36M	-1.16M	-10.51M	-8.92M	-7.30M	-13.04M	-18.80M	-14.96M	-15.73M	-6.68M	-4.66M	-3.83M	3.08M	-7.81M	-5.21M	-5.21M	-3.63M	N/A	-929.00K
EBITDA Margin	-32.60%	-31.55%	-158.63%	-11.70%	-159.24%	-71.28%	-40.07%	-109.57%	-429.06%	-1,419.35%	-452.29%	-96.21%	-42.27%	-39.28%	19.62%	-116.16%	-88.03%	-339.99%	0.00%	0.00%	0.00%
EBIT	-9.60M	-23.88M	-11.17M	-11.16M	-9.43M	-6.54M	-7.40M	-13.15M	-18.96M	-15.19M	-16.04M	-7.03M	-5.08M	-4.26M	2.70M	-8.11M	-5.39M	-5.29M	-3.46M	-2.80M	-977.00K
EBIT Margin	-65.22%	-165.81%	-132.69%	-112.37%	-142.87%	-52.29%	-40.59%	-110.52%	-432.80%	-1,441.37%	-461.32%	-101.12%	-46.13%	-43.65%	17.24%	-120.68%	-91.12%	-344.81%	0.00%	0.00%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31